tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Financial Statements

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Financial Overview

BrightPath Biotherapeutics Co.Ltd.'s market cap is currently ¥5.99B. The company's EPS TTM is ¥-1.94; its P/E ratio is -4.59; BrightPath Biotherapeutics Co.Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.13M¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M
Gross Profit¥ 1.10M¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M
Operating Income¥ -1.16B¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B
EBITDA¥ -1.15B¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B
Net Income¥ -1.15B¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B
Balance Sheet
Cash & Short-Term Investments¥ 810.47M¥ 1.06B¥ 1.53B¥ 2.31B¥ 3.27B
Total Assets¥ 1.12B¥ 1.23B¥ 1.70B¥ 2.77B¥ 3.75B
Total Debt¥ 25.00M¥ 112.50M¥ 0.00¥ 87.50M¥ 0.00
Net Debt¥ -785.47M¥ -944.86M¥ -1.53B¥ -2.22B¥ -3.27B
Total Liabilities¥ 195.62M¥ 251.27M¥ 133.91M¥ 239.73M¥ 211.79M
Stockholders' Equity¥ 924.99M¥ 978.99M¥ 1.57B¥ 2.53B¥ 3.54B
Cash Flow
Free Cash Flow¥ -1.25B¥ -1.16B¥ -1.21B¥ -1.53B¥ -1.81B
Operating Cash Flow¥ -1.25B¥ -1.16B¥ -1.20B¥ -1.51B¥ -1.77B
Investing Cash Flow¥ -1.37M¥ -7.65M¥ -1.76M¥ -17.57M¥ -36.21M
Financing Cash Flow¥ 1.00B¥ 690.96M¥ 432.10M¥ 569.23M¥ 2.05B
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History

BrightPath Biotherapeutics Co.Ltd. Debt to Assets

BrightPath Biotherapeutics Co.Ltd. Cash Flow

BrightPath Biotherapeutics Co.Ltd. Forecast EPS vs Actual EPS